Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
One thing I tell every patient: AOD-9604 is not currently FDA-approved as a finished drug product in the United States
Youre not pulling out the skin and using that to get the lift
Always discuss your treatment goals with your clinician, especially if youre using a GLP-1 to manage menopause-related weight changes
In a combined fertility and prenatal and postnatal study in male and female rats at subcutaneous doses up to 0.36 mg/kg/day, which was approximately 50 times the recommended human subcutaneous starting dose of 0.2 Units/kg/day (0.007 mg/kg/day), maternal toxicity due to dose-dependent hypoglycemia, including some deaths, was observed
Realistically, 2026 or 2027 is the earliest plausible window, and that assumes Phase 3 results are strong and there are no unexpected safety signals
compounding pharmacies from prescribing it
US$ 20.77
US$ 23.50
US$ 23.47
US$ 23.64
